Study Evaluating TMI-005 in Active Rheumatoid Arthritis
Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
The primary objective of this clinical research study is to compare the efficacy and the
safety of 3 dose levels of oral TMI-005 in comparison with placebo in subjects with active
Rheumatoid Arthritis (RA) who have been receiving stable doses of Methotrexate (MTX).